Published in Am J Perinatol on November 01, 2001
Teratomas of the neck and mediastinum in children. Pediatr Surg Int (2006) 1.24
EXIT procedure in twin pregnancy: a series of three cases from a single center. BMC Pregnancy Childbirth (2014) 0.75
Congenital Giant Teratoma Arising from the Hard Palate: A Rare Clinical Presentation. J Clin Diagn Res (2016) 0.75
Pharmacology of nociceptin and its receptor: a novel therapeutic target. Br J Pharmacol (2000) 1.97
Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice. Br J Pharmacol (2008) 1.46
Preventing abnormalities in signal transduction of T cells in cancer: the promise of cytokine gene therapy. Immunol Today (1996) 1.45
Time and frequency domain estimates of spontaneous baroreflex sensitivity provide early detection of autonomic dysfunction in diabetes mellitus. Diabetologia (1997) 1.45
A new selective antagonist of the nociceptin receptor. Br J Pharmacol (1998) 1.41
Spontaneous resolution of cystic hygroma in a 46,XX normal female. Prenat Diagn (1990) 1.40
Efficacy and safety of nadroparin in the treatment of pregnant women with antiphospholipid syndrome: a prospective cohort study. Lupus (2005) 1.38
Address and message sequences for the nociceptin receptor: a structure-activity study of nociceptin-(1-13)-peptide amide. J Med Chem (1997) 1.36
Hypothyroidism and polyneuropathy. J Neurol Neurosurg Psychiatry (1989) 1.30
Presence and bronchomotor activity of protease-activated receptor-2 in guinea pig airways. Am J Respir Crit Care Med (2000) 1.24
Brain auditory activation measured by near-infrared spectroscopy (NIRS) in neonates. Pediatr Res (2001) 1.18
Characterization of [Nphe(1)]nociceptin(1-13)NH(2), a new selective nociceptin receptor antagonist. Br J Pharmacol (2000) 1.18
Eight years' experience with foreign-body aspiration in children: what is really important for a timely diagnosis? J Pediatr Surg (1999) 1.18
Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile. Br J Anaesth (2009) 1.15
High prevalence of a rare hepatitis C virus in patients treated in the same hemodialysis unit: evidence for nosocomial transmission of HCV. Kidney Int (1995) 1.09
Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies. Naunyn Schmiedebergs Arch Pharmacol (1999) 1.08
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay. Br J Pharmacol (1998) 1.07
Early impairment of large artery structure and function in type I diabetes mellitus. Diabetologia (1999) 1.03
Bronchogenic cysts of the neck: a rare localization and review of the literature. Acta Otorhinolaryngol Ital (2009) 1.03
Function of negative charge in the "address domain" of deltorphins. J Med Chem (1991) 1.02
Nociceptin/orphanin FQ receptor ligands. Peptides (2000) 1.02
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist. J Med Chem (1998) 1.02
The mouse vas deferens: a pharmacological preparation sensitive to nociceptin. Eur J Pharmacol (1996) 1.00
Further studies on nociceptin-related peptides: discovery of a new chemical template with antagonist activity on the nociceptin receptor. J Med Chem (2000) 1.00
Effect of the three-dimensional structure on the deamidation reaction of ribonuclease A. J Pept Res (1999) 0.98
Rosiglitazone modifies the adipogenic potential of human muscle satellite cells. Diabetologia (2006) 0.96
Design and development of nanovehicle-based delivery systems for preventive or therapeutic supplementation with flavonoids. Curr Med Chem (2010) 0.95
Prevalence of undiagnosed coeliac syndrome in osteoporotic women. J Intern Med (2001) 0.95
Interaction of deltorphin with opioid receptors: molecular determinants for affinity and selectivity. Peptides (1993) 0.95
Characterization of the locomotor activity-inhibiting effect of nociceptin/orphanin FQ in mice. Naunyn Schmiedebergs Arch Pharmacol (2001) 0.94
Perspectives of protein kinase C (PKC) inhibitors as anti-cancer agents. Mini Rev Med Chem (2009) 0.94
Selective opioid dipeptides. Biochem Biophys Res Commun (1994) 0.94
Increased adipogenic conversion of muscle satellite cells in obese Zucker rats. Int J Obes (Lond) (2010) 0.93
Neonatal ovarian cysts: management and follow-up. Pediatr Surg Int (2000) 0.93
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test. Eur J Neurosci (2003) 0.92
What peptides these deltorphins be. Prog Neurobiol (1999) 0.91
In vitro and in vivo pharmacological profile of UFP-512, a novel selective delta-opioid receptor agonist; correlations between desensitization and tolerance. Br J Pharmacol (2007) 0.91
Mortality rate and outcome factors in mixed cryoglobulinaemia: the impact of hepatitis C virus. Scand J Rheumatol (2010) 0.91
Total body water estimation using bioelectrical impedance: a meta-analysis of the data available in the literature. Acta Diabetol (2003) 0.89
[Nphe(1)]nociceptin-(1-13)-NH(2) antagonizes nociceptin effects in the mouse colon. Eur J Pharmacol (1999) 0.89
[Dmt1]N/OFQ(1-13)-NH2: a potent nociceptin/orphanin FQ and opioid receptor universal agonist. Br J Pharmacol (2013) 0.88
Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice. Naunyn Schmiedebergs Arch Pharmacol (2004) 0.88
The nociceptin/orphanin FQ receptor antagonist, [Nphe1]NC(1-13)NH2, potentiates morphine analgesia. Neuroreport (2000) 0.88
Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget's disease of bone. Bone (2006) 0.87
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives. Br J Pharmacol (2014) 0.87
Solution and solid-state structure of the diketopiperazine of tyrosyl-tetrahydroisoquinoline-3-carboxylic acid. Int J Pept Protein Res (1995) 0.86
Synthesis and pharmacological activity of dermorphin and its N-terminal sequences. Int J Pept Protein Res (1982) 0.86
Pharmacological profile of hemokinin 1: a novel member of the tachykinin family. Life Sci (2002) 0.86
Pharmacology of [Tyr1]nociceptin analogs: receptor binding and bioassay studies. Naunyn Schmiedebergs Arch Pharmacol (1999) 0.86
Na+ mechanism of delta-opioid receptor induced protection from anoxic K+ leakage in the cortex. Cell Mol Life Sci (2009) 0.86
Pharmacological characterization of nociceptin receptor: an in vitro study. Can J Physiol Pharmacol (1997) 0.86
[Post-intubation subglottal stenosis in children: risk factors and prevention in pediatric intensive care]. Minerva Anestesiol (2000) 0.85
Oral iron chelating therapy. A single center interim report on deferiprone (L1) in thalassemia. Haematologica (1998) 0.85
Pycnodysostosis: review and case report. Minerva Stomatol (2014) 0.85
Structure/function relationships in the hemoglobin components from moray (Muraena helena). Eur J Biochem (1995) 0.85
Studies on the antinociceptive effect of [Nphe1]nociceptin(1-13)NH2 in mice. Neurosci Lett (2001) 0.84
Post-transcriptional regulation of MHC class II expression in human T cells. Cell Immunol (1992) 0.84
Parallel bioassay of 39 tachykinins on 11 smooth muscle preparations. Structure and receptor selectivity/affinity relationship. Peptides (2000) 0.83
Progression of functional and structural cardiac alterations in young normotensive uncomplicated patients with type 1 diabetes mellitus. J Hypertens (2001) 0.83
Postpartum hostility and prolactin. Int J Psychiatry Med (1983) 0.83
B chromosomes in Crustacea Decapoda. Cytogenet Genome Res (2004) 0.82
The novel delta opioid receptor agonist UFP-512 dually modulates motor activity in hemiparkinsonian rats via control of the nigro-thalamic pathway. Neuroscience (2009) 0.82
Dermorphin inhibits spinal nociceptive flexion reflex in humans. Brain Res (1986) 0.82
Stereospecificity of amino acid side chains in deltorphin defines binding to opioid receptors. J Med Chem (1992) 0.82
The usefulness of routine preoperative laboratory tests for one-day surgery in healthy children. Paediatr Anaesth (1998) 0.82
Endogenous nociceptin signaling and stress-induced analgesia. Neuroreport (2001) 0.82
Nociceptin receptor binding in mouse forebrain membranes: thermodynamic characteristics and structure activity relationships. Br J Pharmacol (1998) 0.82
Neuropeptide S selectively inhibits the release of 5-HT and noradrenaline from mouse frontal cortex nerve endings. Br J Pharmacol (2009) 0.82
Proton magnetic resonance studies on dermorphin and its peptide fragments. Biopolymers (1984) 0.82
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus. Life Sci (1999) 0.81
Synthesis and receptor binding analysis of dermorphin hepta-, hexa- and pentapeptide analogues. Evidence for one- and two-side binding models for the mu-opioid receptor. Int J Pept Protein Res (1993) 0.81
New delta-opioid antagonists as pharmacological probes. Trends Pharmacol Sci (1998) 0.81
Structure-activity studies of the Phe(4) residue of nociceptin(1-13)-NH(2): identification of highly potent agonists of the nociceptin/orphanin FQ receptor. J Med Chem (2001) 0.81
Emerging evidence for neurotensin receptor 1 antagonists as novel pharmaceutics in neurodegenerative disorders. Mini Rev Med Chem (2009) 0.80
[The EX-utero Intrapartum Technique (EXIT) procedure in Italy]. Minerva Ginecol (2001) 0.80
Design of mu selective opioid dipeptide antagonists. FEBS Lett (1997) 0.80
Acid catalysis in the formation of dioxopiperazines from peptides containing tetrahydroisoquinoline-3-carboxylic acid at position 2. Int J Pept Protein Res (1995) 0.80
Opioid receptor selectivity reversal in deltorphin tetrapeptide analogues. Biochem Biophys Res Commun (1991) 0.80
Major and 5S ribosomal sequences of the largemouth bass Micropterus salmoides (Perciformes, Centrarchidae) are localized in GC-rich regions of the genome. Chromosome Res (2000) 0.80
Nociceptin binding sites in frog (Rana esculenta) brain membranes. Biochem Biophys Res Commun (1999) 0.80
Opioid receptor selectivity alteration by single residue replacement: synthesis and activity profile of [Dmt1]deltorphin B. Eur J Pharmacol (1996) 0.80
Opioid pseudopeptides containing heteroaromatic or heteroaliphatic nuclei. Peptides (2000) 0.80
Inverse agonism by Dmt-Tic analogues and HS 378, a naltrindole analogue. Eur J Pharmacol (2000) 0.79
Design and synthesis of 1-aminocycloalkane-1-carboxylic acid-substituted deltorphin analogues: unique delta and mu opioid activity in modified peptides. J Med Chem (1996) 0.79
Opioid infidelity: novel opioid peptides with dual high affinity for delta- and mu-receptors. Trends Neurosci (1996) 0.79
Rational design of dynorphin A analogues with delta-receptor selectivity and antagonism for delta- and kappa-receptors. Bioorg Med Chem (1998) 0.79
Synthesis and activity of new linear and cyclic peptide T derivatives. Arzneimittelforschung (1994) 0.79
Surfactant protein C is recycled from the alveoli to the lamellar bodies. Am J Physiol (1992) 0.79
[tBu-D-Gly5]NPS, a pure and potent antagonist of the neuropeptide S receptor: in vitro and in vivo studies. Peptides (2012) 0.79
Distribution and pharmacological properties of the GABAA/benzodiazepine/chloride ionophore receptor complex in the brain of the fish Anguilla anguilla. J Neurochem (1989) 0.79
Alpha-beta-dehydro-amino acid residues in the design of peptide structures. Molecular and crystal structures of two folded dehydro peptides. Int J Biol Macromol (1992) 0.79
[Cardiologic aspects of carbon monoxide poisoning]. Cardiologia (1989) 0.78
Teriparatide's effects on quantitative ultrasound parameters and bone density in women with established osteoporosis. Osteoporos Int (2006) 0.78
Structure-activity relationships of nociceptin and related peptides: comparison with dynorphin A. Peptides (2000) 0.78
A case of septic miscarriage, a probable complication of chorion villus sampling. Prenat Diagn (1988) 0.78
Differential knockdown of delta-opioid receptor subtypes in the rat brain by antisense oligodeoxynucleotides targeting mRNA. Antisense Nucleic Acid Drug Dev (1999) 0.78
New insights on mu/delta selectivity of opioid peptides: conformational analysis of deltorphin analogues. Biopolymers (1991) 0.78